THE PHARMACOKINETICS OF YM150, AN ORAL DIRECT FACTOR XA INHIBITOR, EXHIBITS DOSE PROPORTIONALITY WITH NO CLINICALLY RELEVANT EFFECT OF ETHNICITY OR GENDER

Translated title of the contribution: THE PHARMACOKINETICS OF YM150, AN ORAL DIRECT FACTOR XA INHIBITOR, EXHIBITS DOSE PROPORTIONALITY WITH NO CLINICALLY RELEVANT EFFECT OF ETHNICITY OR GENDER

D. Groenendaal, T. Kadokura, G. Andersen, J. de Rooij, M. Drs. Heeringa, F. Verheggen, H. Heinzerling

Research output: Contribution to conferenceAbstractOther research output

Translated title of the contributionTHE PHARMACOKINETICS OF YM150, AN ORAL DIRECT FACTOR XA INHIBITOR, EXHIBITS DOSE PROPORTIONALITY WITH NO CLINICALLY RELEVANT EFFECT OF ETHNICITY OR GENDER
Original languageUndefined/Unknown
PagesS86
Number of pages1
Publication statusPublished - 2011
EventUnknown event -
Duration: 26 Aug 201430 Aug 2014

Conference

ConferenceUnknown event
Period26/08/1430/08/14

Cite this